Artificial Intelligence In Life Sciences Market 2024 - By Size, Share Analysis, Future Insights, Current Trends And Global Growth Outlook By 2033

The new report published by The Business Research Company, titled ""Artificial Intelligence In Life Sciences Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033"", delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.

As per the report, the artificial intelligence in life sciences market size has grown exponentially in recent years. It will grow from $2.35 billion in 2023 to $2.92 billion in 2024 at a compound annual growth rate (CAGR) of 24.2%. The artificial intelligence in life sciences market size is expected to see exponential growth in the next few years. It will grow to $6.82 billion in 2028 at a compound annual growth rate (CAGR) of 23.6%.

Download Free Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=13587&type=smp

Surge In Remote Patient Monitoring Boosts AI Adoption In Lifesciences
The increasing interest in real-time remote patient monitoring (RPM) systems is expected to propel the growth of artificial intelligence in the life sciences market going forward. A remote patient monitoring system is a technology-driven healthcare solution designed to monitor patients' health outside of traditional healthcare settings. AI in life sciences contributes significantly to remote patient monitoring by providing continuous, personalized, and data-driven insights that enable proactive healthcare management. For instance, in August 2023, according to a survey conducted by Vivalink, a US-based digital healthcare company, clinicians' use of remote patient monitoring (RPM) grew by 20% in 2021 to 81% in 2022, increasing by 305%. Therefore, the increasing interest in real-time remote patient monitoring (RPM) systems is driving the growth of artificial intelligence in the life sciences market.

Technological Advancements In The Artificial Intelligence In Life Sciences Market
Major companies operating in the artificial intelligence in the life sciences market are focusing on innovative products with technological advancements, such as drug discovery software, to sustain their position in the market. Drug discovery software refers to a category of computer programs and applications designed to assist pharmaceutical and biotechnology researchers in the process of discovering new drugs. For instance, in December 2023, Merck, a Germany-based science and technology company, unveiled AIDDISON, a groundbreaking drug discovery software. As the first-ever of its kind, it connects virtual molecule design with real-world manufacturability, using generative AI, machine learning, and computer-aided drug design. AIDDISON efficiently identifies drug candidates from vast possibilities, considering crucial properties like non-toxicity and solubility. Its ability to bridge the gap between virtual molecule design and real-world manufacturability is a notable application of artificial intelligence in the life sciences sector.

The artificial intelligence in life sciences market covered in this report is segmented -

1) By Offering: Software, Hardware, Services
2) By Deployment: On-Premises, Cloud-Based
3) By Application: Drug Discovery, Medical Diagnosis, Biotechnology, Clinical Trails, Precision and Personalized Medicine, Patient Monitoring

Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=13587&type=discount

Major companies operating in the artificial intelligence in life sciences market report are Google LLC, Microsoft Corporation, Intel Corporation, IBM Corporation, Medtronic PLC, Nvidia Corporation, Novo Nordisk A/S, Siemens Healthineers AG, Philips Healthcare, Babylon Healthcare Services Ltd., Komodo Health Inc., Modernizing Medicine Inc., Viz.ai Inc., Butterfly Network Inc., Augmedix, AiCure LLC, HealthTap Inc., Welltok Inc., Enlitic Inc., PathAI Inc., Nano-X Imaging Ltd., Berg LLC, Insitro, Sense.ly Inc., Subtle Medical Inc., Medasense Biometrics Limited, Immunai, Atomwise Inc., Freenome Holdings Inc., CloudMedX Inc.

Contents of the report:
1. Executive Summary
2. Artificial Intelligence In Life Sciences Market Report Structure
3. Artificial Intelligence In Life Sciences Market Trends And Strategies
4. Artificial Intelligence In Life Sciences Market - Macro Economic Scenario
5. Artificial Intelligence In Life Sciences Market Size And Growth
…..
27. Artificial Intelligence In Life Sciences Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Explore the report store to make a direct purchase of the report @ https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-life-sciences-global-market-report

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.